27 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
or Commercialization of Compounds or Products by Processa, its Affiliates or Sublicensees, including all Third-Party Claims involving death or bodily injury caused
424B4
1g3j8gn278uyn3ha
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-10.1
7a9sl5dig7 nurndm2
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
98qm9kuu as278u
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
x300y
20 Aug 20
Entry into a Material Definitive Agreement
9:30am